IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Michigan

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Michigan $ 18,138,110.55
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Aastrom Biosciences, Inc. A Phase III Stage Expanded, Autologous Stem Cell Product to Treat Severe CV Disease $ 244,479.24  
Accord Biomaterials Inc Improved central venous and hemodialysis catheters to minimize infection and clotting $ 211,615.81 $ 32,863.44
Accord Biomaterials, Inc. Coronary stent with passivated surfaces to address restenosis and late-stage thrombosis $ 178,815.24 $ 65,664.01
Accord Biomaterials, Inc. Point-of-Care Diagnostic and Therapy Management Tool for Pulmonary Arterial Hypertension $ 20,493.75 $ 189,918.09
Accuri Cytometers Inc Development of the Accuri CS Clinical Flow Cytometry System $ 244,479.25  
Adeona Pharmaceuticals, Inc. Estriol (Trimesta) $ 35,493.50 $ 208,985.75
Adeona Pharmaceuticals, Inc. Zinthionein and ZincMonoCysteine $ 133,439.00 $ 111,040.25
AlphaCore Pharma, LLC Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion $ 244,479.25  
Angott Medical Products, LLC Multi-modality Breast Cancer Tester $ 19,157.00 $ 225,322.25
ApoLife, Inc Secretary IgA for orally applied therapy for treatment of Clostridium difficile infection. $ 57,509.66 $ 143,400.00
Armune BioScience Inc Molecular Diagnostics for Early Detection of Cancer $ 244,479.24  
Art Optical Contact Lens, Inc. Therapeutic treatment of irregular corneas $ 39,571.00 $ 44,847.50
AureoGen Bioscience Inc. A novel antibiotic for the treatment of drug resistant bacterial infections $ 136,897.60 $ 107,581.64
Aursos, Inc. Aursos BB for primary & secondary osteoporosis and bone-building (anabolic) activity $ 36,335.00 $ 4,618.00
Cardiavent Inc. Development of CARD-024 for the treatment of hypertension and heart failure $ 66,868.50 $ 177,610.75
Cayman Chemical Company Inc EP4 Project   $ 172,016.50
Cayman Chemical Company Inc H-PGDS Inhibition Project $ 96,509.00 $ 31,848.00
Cayman Chemical Company, Inc Tetranor Prostaglandin E Metabolite ELISA Project $ 11,769.00 $ 11,557.50
Cerenis Therapeutics Inc HDL-Mimetic Peptide/Phospholipid complex (CER-522) $ 165,319.49 $ 79,159.76
Cerenis Therapeutics Inc. CER-627 Low Flushing Niacin $ 117,626.86 $ 63,100.93
Cerenis Therapeutics, Inc. CER-002 $ 43,428.26 $ 95,307.06
Compendia Bioscience, Inc. Oncopredictor $ 122,116.50 $ 122,362.74
CytoPherx, Inc Selective CytoPheretic Device $ 244,479.25  
Delphinus Medical Technologies, inc. Commercialization of SoftVue for early detection of Breast cancer $ 238,705.00 $ 5,774.25
Esperion Therapeutics, Inc ETC-1002 $ 244,479.24  
Genetics Squared, Inc. Commercialization of a Stage I and II colorectal Cancer Recurrence Prognostic Technology $ 244,479.24  
Great Lakes BioSciences Noninvasive cortical stimulation treatment of pain in fibromyalgia $ 118,246.00 $ 126,233.25
Housey Pharmaceutical Research Laboratories, LLC Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous Leukemia $ 62,210.50 $ 182,268.75
HOUSEY PHARMACEUTICAL RESEARCH LABORATORIES, LLC DISCOVERY AND DEVELOPMENT OF ANTI DIABETIC DRUGS $ 201,356.00 $ 43,123.25
Hygieia Inc PRIVATE-DOC $ 80,761.72 $ 163,717.53
Innovative BioTherapies, Inc Bioengineered Cellular/ Biomimetic-based Therapeutic System for treatment of SIRS $ 244,479.24  
Integrated Sensing Systems Wireless Pressure Monitoring Implant for Tailored Medication of Cardiovascular Diseases $ 244,479.24  
Integrated Sensing Systems A Microfluidic-Based Therapeutic Drug Infusion System $ 244,479.25  
IPGDx LLC Determining an infectious process prior to syndromic findings as a biosurveillance tool   $ 244,479.25
IPGDx, LLC Detection of Disease Severity & Progression, Treatment Effectiveness & Survival in Cancer   $ 244,479.24
Life Magnetics, Inc Sensitive, Rapid Diagnostic device for Antibiotic Susceptibility Testing   $ 162,127.08
LPIT SOLUTIONS, INC TRACKCORE SOFTWARE FOR OR IMPLANT MANAGEMENT $ 210,295.33 $ 34,183.92
LVAD Technology Inc. Via-Derm-2, a novel long-term percutaneous access device $ 85,079.32 $ 159,399.93
Lycera Corp ATPase Oral Therapeutic $ 244,479.24  
Lycera Corp. RoR Gamma Therapeutic $ 244,479.24  
Meditrina Pharmaceuticals Inc. MPI-676 $ 12,860.00 $ 99,477.63
Metabolic Solutions Development Company Novel Insulin Sensitizing Agents for Therapy in Type 2 Diabetes $ 244,479.24  
Michigan Critical Care Consultants Inc DBA MC3 Inc Hyperthermia device for cancer treatment $ 36,179.85 $ 98,601.27
Michigan Critical Care Consultants Inc DBA MC3 Inc Catheter Enterogenesis Device Development   $ 40,746.68
Michigan Critical Care Consultants, Inc. DBA MC3, Inc. Pediatric blood pump development $ 93,822.77 $ 150,656.47
Michigan Critical Care Consultants, Inc. DBA MC3, Inc. Artificial Lung Development $ 93,587.07 $ 150,892.17
Michigan Critical Care Consultants, Inc., DBA MC3, Inc. Bidirectional Arterial Cannula Development $ 80,991.20 $ 163,488.04
Michigan Critical Care Consultants, Inc., DBA MC3, Inc. Annuloplasty Ring for Heart Valve Disease $ 17,393.01 $ 46,276.11
Michigan Critical Care Consultants, Inc., DBA MC3, Inc. Automatic Perfusion System Development $ 13,314.69 $ 70,696.82
Michigan Critical Care Consultants, Inc., DBA MC3, Inc. Simple Ventricular Assist Device Development   $ 53,422.38
MICHIGAN TECHNOLOGY & RESEARCH INSTITUTE, LLC GENETIC CHARACTERIZATION OF FIBROSIS & INFLAMMATORY SUSCEPTIBILITY IN CHRONIC KIDNEY DISEASE $ 22,191.00 $ 8,518.71
NanoBio Corporation Novel Nebulized Therapy for Cystic Fibrosis $ 244,479.25  
NanoBio Corporation Novel Topical Therapy for Herpes Labialis $ 244,479.25  
NanoBio Corporation Novel Intranasal Vaccine Adjuvant $ 244,479.25  
NanoBio Corporation Novel Intranasal 23- Valent Pneumococcal Vaccine $ 244,479.25  
NanoBio Corporation Novel Topical Anti-fungal Therapy for Tinea Capitis and Onychomycosis $ 244,479.25  
NanoVir, L.L.C. Therapeutic Development of Antiviral Compounds that Target Human Papillomaviruses (HPV) $ 244,479.24  
Nephrx Corporation NX001 Treatment of Acute Kidney injury $ 244,479.24  
NEPHRX Corporation NS002 Treatment of Oral Mucositis $ 91,845.50 $ 152,633.74
NeuroNexus Technologies, Inc. Deep Brain Stimulation $ 162,088.50 $ 47,855.50
Novalung, Inc. Development of pump for use with artificial lung $ 226,495.16 $ 17,984.08
Nustep, Inc Metabolic Cost of Recumbent Exercise in Overweight Individuals   $ 24,330.00
Nymirum Inc Alzheimer's Project $ 17,248.00 $ 227,231.25
Nymirum Inc Hepatitis C Project $ 9,764.50 $ 234,714.75
Nymirum, Inc Myotonic Dystrophy Project $ 30,283.50 $ 214,195.75
OtoMedicine Inc Prevention of Drug Induced Hearing Loss (DIHL) by AuraQuell $ 98,011.00 $ 146,468.25
Phrixus Pharmaceuticals, Inc Heart Failure $ 168,430.00 $ 76,049.24
Phrixus Pharmaceuticals, Inc Duchenne Muscular Dystrophy $ 168,430.00 $ 76,049.24
ProNAI Therapeutics, Inc A Phase 1 Study of PNT2258 in Patients with Advanced Solid Tumors $ 30,965.00 $ 213,514.24
QuatRx Pharmaceuticals Company Ospemifene $ 244,479.25  
RealBio Technology, Inc. Biorealistic Tissue models for Drug Discovery and Testing $ 93,800.00 $ 150,679.24
RetroSene Therapeutics LLC aka RetroSense Therapeutics LLC Gene therapy for vision restoration $ 1,750.00 $ 161,094.43
Rockwell Medical Technologies, Inc. Soluble Ferric Pyrophosphate (SFP) indicated for the treatment of iron deficiency anemia $ 244,479.24  
Rubicon Genomics, Inc Development of PicoPlex -NGS Kits $ 85,674.50 $ 99,166.50
Rubicon Genomics, Inc. Development of MethylPlex ™ -NGS Kits $ 80,501.00 $ 129,187.00
Sonetics Ultrasound, Inc. Fully-sampled 2D/planar ultrasound transducer technology $ 185,276.47 $ 59,202.78
Swift Biosciences Inc Development of High Sensitivity Genetic Tests for Detection and Assessment of Cancer   $ 244,479.24
Tangent Medical Technologies Peripheral intravenous therapeutic delivery device   $ 244,479.25
TCH Pharmaceuticals, Inc Imidazoline-based Inhibitors $ 17,519.50 $ 26,431.62
Therapeutic System Research Laboratories, Inc. (TSRL) Anti-Influenza Therapeutic $ 53,603.56 $ 43,987.62
Therapeutic Systems Research Laboratories, Inc (TSRL) Cidofovir, Nucleoside Prodrug for Antiviral Treatment $ 244,479.25  
Therapeutic Systems Research Laboratories, Inc. (TSRL) Bile Acid Carrier $ 85,919.29 $ 24,184.42
Therapeutic Systems Research Laboratories, Inc. (TSRL) Inflammatory Bowel Disease Therapeutic $ 45,127.53 $ 75,793.37
Tolera Therapeutics, Inc TOL 101 in Phase 2 short course immune induction therapy for chronic immune disease $ 244,479.24  
Ultrasound Medical Devices Inc imaging of cardiovascular mechanical function for assessment diagnosis and therapy guidance $ 221,258.00 $ 23,221.25
Velcura Therapeutics, Inc. VEL-0230 an Orally Available, Disease Modifying Anti-Rheumatic Drug (DMARD) $ 194,016.10  
Xoran Technologies Inc Xoran xCAT $ 244,479.25  
Xoran Technologies, Inc. Xoran MiniCAT $ 244,479.25  
zuSyn, Inc. Development of Novel Taxanes for the Treatment of Cancer $ 3,280.20 $ 1,704.58

 

Page Last Reviewed or Updated: 07-Apr-2014